Pediatrix Strengthens Tennessee Maternal Health Services with Key Partnership
Pediatrix Partners with Tennessee Maternal-Fetal Medicine to Expand Maternal Care Services Pediatrix Medical Group, Inc., a prominent provider of physician services across the United States, has announced a strategic expansion of its maternal health services in Middle Tennessee through a…
GE HealthCare to Lead Major EU-Funded IHI Consortium Advancing Cardio-Oncology Care in Europe
Driving AI-powered early detection, risk prediction, and integrated care pathways to improve cardiovascular outcomes for cancer patients and survivors across Europe. The newly launched COMPASS consortium represents one of the most ambitious and strategically important public-private collaborations under the European…
Agenus to Host March 2026 Webcast on Advancing BOT + BAL Immunotherapy Across Tumors
Agenus to Host March 2026 Webcast on Advancing BOT+BAL Immunotherapy and Expanding Patient Access Agenus , a biotechnology company at the forefront of immuno-oncology innovation, has announced that it will host its March 2026 Stakeholder Webcast, continuing its efforts to…
Rubedo Reports Positive Phase I Results for RLS-1496 in Skin Conditions
Rubedo Life Sciences Reports Encouraging Phase I Results for RLS-1496 in Plaque Psoriasis, Atopic Dermatitis, and Aging Skin Rubedo Life Sciences, a clinical-stage biotechnology company focused on developing innovative therapies targeting cellular aging, has reported encouraging preliminary findings from its…
Long Bridge Medical Gains FDA Clearance for U.S. Pivotal Study of LensOne Capsular Bag
FDA Clears Long Bridge Medical to Launch GOLDEN GATE Pivotal Trial for LensOne™ Prosthetic Capsular Bag Long Bridge Medical, Inc., a U.S.-based medical device innovator focused on advancing ophthalmic surgical solutions, has announced a major regulatory milestone with the U.S.…
Telemedicine Solutions Help Rural Hospitals Boost Revenue, Cut Transfers, and Improve Care Access
Telemedicine Boosts Rural Hospitals’ Revenue and Care Access Rural healthcare in the United States is at a pivotal moment. Nearly one in five Americans—more than 60 million people—live in rural communities, where access to high-quality, specialized medical care remains a…
Brightseed Launches First Clinically Validated Enterprise AI Platform
Brightseed Unveils First Clinically Validated Enterprise AI Platform Backed by 10+ Years of Scientific Research Brightseed is redefining the future of health sciences innovation with the launch of its groundbreaking enterprise AI platform—an integrated system designed to connect discovery, development,…
Banyan, HoloMD Report 90-Day AI Recovery Pilot Results
Banyan Treatment Centers and HoloMD Reveal Promising 90-Day Pilot Results for AI-Driven Post-Discharge Recovery Care In a significant step forward for post-discharge recovery care, Banyan Treatment Centers, a national leader in substance use disorder and co-occurring mental health treatment, has…
Carna Health Named to Fortune’s 2026 List of America’s Most Innovative Companies
Carna Health Named to Fortune’s 2026 List of America’s Most Innovative Companies Carna Health, a pioneering digital health company focused on transforming kidney care and addressing cardio-kidney metabolic (CKM) conditions, has earned a place on Fortune’s prestigious list of America’s…
CompHealth Earns Joint Commission Recognition for Quality & Safety
CompHealth Earns Joint Commission Certification, Reinforcing Commitment to Quality and Safety in Healthcare Staffing CompHealth, a leading provider of healthcare staffing solutions specializing in advanced practice, therapy, and laboratory services, has achieved the prestigious Health Care Staffing Services (HCSS) Certification…
Centurion Foundation Saves Two At-Risk Rhode Island Safety Net Hospitals
Centurion Foundation Secures Future of Two Rhode Island Safety-Net Hospitals Through Non-Profit Transition In a major development for healthcare access in Rhode Island, the Centurion Foundation has successfully stabilized two critical safety-net hospitals that were previously at risk of closure.…
FDA Approves Corcept’s Lifyorli™ Combo for Platinum-Resistant Ovarian Cancer
U.S. Food and Drug Administration Approves Corcept’s Lifyorli™ (relacorilant) Combination Therapy for Platinum-Resistant Ovarian Cancer Corcept Therapeutics Incorporated has announced a major regulatory milestone with the approval of its novel therapy, Lifyorli™ (relacorilant), by the U.S. Food and Drug Administration.…